Zentalis Pharmaceuticals Llc (ZNTL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $157.22M
Last updated: Nov 17, 2026 at 4:23 PM ET
Zentalis Pharmaceuticals Llc (ZNTL) Stock Chart
Zentalis Pharmaceuticals Llc (ZNTL) has a latest price of $1.49 on Nov 17, 2026, 78.6% below its 52-week high of $6.95. Its price rose 12.0% over the past 12 months. The month-end price fell 97.6% over the 5 years through Oct 2026, a compound annual decline of 52.4%.
Price Chart
From Apr 2020 to Oct 2026, its highest month-end close was $84.06 in Dec 2021 and its lowest $1.16 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ZNTL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ZNTL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 61.0%, and over 6 months it fell 57.9%. The month-end price fell 88.0% over the 3 years through Oct 2026, a compound annual decline of 50.7%.
| Period | Change |
|---|---|
| 1 month | -35.2% |
| 3 months | -61.0% |
| 6 months | -57.9% |
| 12 months | +12.0% |
| 12 months, with dividends | +12.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -88.0% | -50.7% |
| 5 years | -97.6% | -52.4% |
Price by Year
Its best calendar year was 2021, when the price rose 61.8%, and its weakest was 2024, when it fell 80.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.96 | +45.2% |
| 2025 | $1.35 | -55.4% |
| 2024 | $3.03 | -80.0% |
| 2023 | $15.15 | -24.8% |
| 2022 | $20.14 | -76.0% |
| 2021 | $84.06 | +61.8% |
Trading Range
The price is 38.8% below its 50-day average of $2.43 and 56.0% below its 200-day average of $3.39.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.49 | |
| 52-week high | $6.95 | -78.6% |
| 52-week low | $1.28 | +16.4% |
| 50-day average | $2.43 | -38.8% |
| 200-day average | $3.39 | -56.0% |
Price Risk
Over 3 years, its largest fall from a peak was 93.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.82 |
| Largest fall, 1 year | -77.5% |
| Largest fall, 3 years | -93.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ZNTL
What is ZNTL's 1-year price change?
Zentalis Pharmaceuticals Llc's price rose 12.0% over the past 12 months. With dividends included, the 12-month total return was 12.0%.
What is ZNTL's 5-year price change?
Zentalis Pharmaceuticals Llc's month-end price fell 97.6% over the 5 years through Oct 2026, a compound annual decline of 52.4%. These figures leave out dividends.
What is ZNTL's 52-week high and low?
Zentalis Pharmaceuticals Llc's 52-week high is $6.95 and its 52-week low is $1.28. Its latest price of $1.49 on Nov 17, 2026 is 78.6% below the high.
What is ZNTL's beta?
Zentalis Pharmaceuticals Llc's 1-year beta against the S&P 500 is 1.82, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.5%.
Is the ZNTL chart free?
Yes. Advanced Charting for ZNTL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ZNTL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors